Back to Search
PHILIP GLYNN, M.D.
M.D.
Medical Oncology Physician
NPI: 1316985617IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
57384(MA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1984
Research & Publications (20)
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
PMID 18349031·Ann Oncol·2008
8-other
Developing an ocean ethic: science, utility, aesthetics, self-interest, and different ways of knowing.
PMID 18798861·Conserv Biol·2009
8-other
The hips influence on low back pain: a distal link to a proximal problem.
PMID 19321904·J Sport Rehabil·2009
8-other
Poorly cemented coral reefs of the eastern tropical Pacific: possible insights into reef development in a high-CO2 world.
PMID 18663220·Proc Natl Acad Sci U S A·2008
7-preclinical
A natural history model of stage progression applied to breast cancer.
PMID 16598706·Stat Med·2007
8-other
Phospholipase B activity and organophosphorus compound toxicity in cultured neural cells.
PMID 16963094·Toxicol Appl Pharmacol·2007
7-preclinical
Short-term effects of thrust versus nonthrust mobilization/manipulation directed at the thoracic spine in patients with neck pain: a randomized clinical trial.
PMID 17341509·Phys Ther·2007
2-rct
A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.
PMID 17032898·J Natl Cancer Inst Monogr·2006
8-other
Timely and appropriate access to healthcare. The way forward--the roles of the players.
PMID 17076374·Healthc Q·2006
8-other
Sustaining change: the imperative for patient access strategies.
PMID 16914942·Healthc Pap·2006
8-other
Inhibition of neurite outgrowth in differentiating mouse N2a neuroblastoma cells by phenyl saligenin phosphate: effects on MAP kinase (ERK 1/2) activation, neurofilament heavy chain phosphorylation and neuropathy target esterase activity.
PMID 16499876·Biochem Pharmacol·2006
7-preclinical
A mechanism for organophosphate-induced delayed neuropathy.
PMID 16309859·Toxicol Lett·2006
7-preclinical
Neuropathy target esterase and phospholipid deacylation.
PMID 16137924·Biochim Biophys Acta·2005
6-review
Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila.
PMID 15772346·J Neurosci·2005
4-observational
Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells.
PMID 15044461·J Biol Chem·2004
7-preclinical
Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration.
PMID 15587436·Stat Methods Med Res·2004
8-other
The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss.
PMID 15035642·Biochemistry·2004
8-other
Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice.
PMID 14749382·Mol Cell Biol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 271 CAREW STREET
SPRINGFIELD, MA 01104 - Phone
- (413) 748-7370
Quick Facts
- NPI
- 1316985617
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile